Neuromuscular blocking drugs Flashcards
What do NMB’s do and what are they used for?
Can completely paralyze skeletal muscle and are primarily used as adjuncts during surgical and orthopedic procedures
Mechanism of action of NMB’s
Antagonizing the action of ACh at the nerve-muscle synapse (neuromuscular junction)
Succinylcholine
The only therapeutically useful neuromuscular blocker that acts as a depolarizing agent
- short acting used in brief procedures
- stimulates autonomic ganglia; stimulates cardiac muscarinic AChR; metabolized by plasma cholinesterase
Apnea
Major adverse reaction to succinylcholine; extending into the postoperative period
Hyperkalemia
Results from release of K+ from the muscle via the nAChRs; and is another adverse reaction to succinylcholine
-Precludes the use of succinylcholine in children; due to undiagnosed skeletalmyopathies
Tubocurarine
Long acting neuromuscular blocker
- autonomic ganglia blockade; high effect on histamine release; no effect on cardiac muscarinic AChR; metabolized in the kidney/liver
- no longer available
Pancuronium
Long acting neuromuscular blocker
- no effect on autonomic ganglia; no effect on histamine release; moderate block on cardiac muscarinic AChR (incr bp or tachycardia); metabolized in the kidney
- concern for patients with heart problems and patients with kidney transplants
Pipercuronium & Doxacurium
Long acting neuromuscular blocker
- no effect on autonomic ganglia; no effect on histamine release; no effect on cardiac muscarinic AChR; metabolized in the kidney
Vercuronium
Intermediate acting neuromuscular blocker
- no effect on autonomic ganglia; no effect on histamine release; no effect on cardiac muscarinic AChR; metabolized in the liver
Atracurium & Cistracurium
Intermediate acting neuromuscular blocker
- no effect on autonomic ganglia; low effect on histamine release; no effect on cardiac muscarinic AChR; spontaneously hydrolyzed in the liver creating laudanosine
- concern for hypotension and bronchoconstriction
Rocuronium
Intermediate acting neuromuscular blocker with rapid onset
- no effect on autonomic ganglia; no effect on histamine release; slight effect on cardiac muscarinic AChR
- Alt for succinylcholine
Mivacurium
Short acting neuromuscular blocker with rapid onset
- no effect on autonomic ganglia; low effect on histamine release; no effect on cardiac muscarinic AChR; metabolized by plasma cholinesterase
- alt to succinylcholine
Response to Succinylcholine
Occurs in two phases. In phase I, there is initial activation followed by receptor blockade resulting from persistent depolarization (leading to Na channel inactivation). In phase II, later, nicotinic receptors will inactivate resulting in repolarization
Succinylcholine + ChE inhibitor
Phase I will be enhanced while phase II will be reversed
Reversal of NMJ blockade
For all blockers except succinylcholine (and mivacurium), reversal may be accelerate by using a cholinesterase inhibitor.
-idea is ACh will compete away the blocker